Diffusion-Weighted MRI Technique Cuts Breast Biopsy Requirements
|
By MedImaging International staff writers Posted on 18 Oct 2015 |

Image: A diagnostic DWIBS MRI mammography demonstrating a lesion (Photo courtesy of DKFZ).
An abbreviated magnetic resonance imaging (MRI) protocol could reduce unnecessary breast biopsies by providing additional information on suspicious X-ray screening mammography findings, according to a new study.
Researchers at the German Cancer Research Center (DKFZ; Heidelberg, Germany), University Hospital Heidelberg (Germany), and other institutions conducted a study to evaluate the ability of an abbreviated MRI protocol consisting of maximum intensity projections (MIPs) from diffusion-weighted imaging with background suppression (DWIBS) and unenhanced morphologic sequences to help predict the likelihood of malignancy on suspicious screening X-ray mammograms, as compared with an abbreviated contrast material-enhanced MRI protocol and a full diagnostic breast MRI protocol.
To do so, 50 women (mean age 57.1 years), who gave informed consent and who had suspicious screening mammograms and an indication for biopsy participated in a prospective study from September 2014 to January 2015. Before biopsy, a full diagnostic contrast-enhanced MRI was performed that included DWIBS. Two abbreviated protocols based on MIPs were evaluated; the first showed the shape and appearance of the lesion; the second displayed its biophysiological properties with DWIBS, a technique that works by assessing the diffusion of water molecules through tissue, since areas of restricted diffusion may indicate malignancy.
The results showed that 25 of the 50 participants had a breast carcinoma. DWIBS achieved a comparable accuracy to that of the full diagnostic and the abbreviated contrast-enhanced MRI protocols, yielding an excellent negative predictive value of 92%. Only pure microcalcification related ductal carcinoma in-situ (DCIS) without solid tumor—a very early stage of breast cancer—was not detected by any of the MRI techniques. The study was published early online on September 11, 2015, in Radiology.
“If the preliminary findings are confirmed, this approach could have a high potential to be used as an adjunct in the clarification process of unclear lesions on X-ray mammography in breast cancer screening,” said lead author Sebastian Bickelhaupt, MD, a radiologist at DKFZ. “This might help to reduce the number of invasive biopsies and the related anxiety in women who have suspicious findings at mammography.”
DWIBS MRI holds several advantages; the images can be obtained in less than seven minutes, compared with more than 30 minutes for a full breast MRI protocol; and the mean reading time using the unenhanced DWIBS method is less than 30 seconds thanks to MIPS, a technique that allows lesion assessment by reading one summation image instead of multiple single-slice images. The technique however, is in its early stages, and as such is not intended as a standalone screening modality but as an adjunct to X-ray mammography and tomosynthesis.
Related Links:
German Cancer Research Center
University Hospital Heidelberg
Researchers at the German Cancer Research Center (DKFZ; Heidelberg, Germany), University Hospital Heidelberg (Germany), and other institutions conducted a study to evaluate the ability of an abbreviated MRI protocol consisting of maximum intensity projections (MIPs) from diffusion-weighted imaging with background suppression (DWIBS) and unenhanced morphologic sequences to help predict the likelihood of malignancy on suspicious screening X-ray mammograms, as compared with an abbreviated contrast material-enhanced MRI protocol and a full diagnostic breast MRI protocol.
To do so, 50 women (mean age 57.1 years), who gave informed consent and who had suspicious screening mammograms and an indication for biopsy participated in a prospective study from September 2014 to January 2015. Before biopsy, a full diagnostic contrast-enhanced MRI was performed that included DWIBS. Two abbreviated protocols based on MIPs were evaluated; the first showed the shape and appearance of the lesion; the second displayed its biophysiological properties with DWIBS, a technique that works by assessing the diffusion of water molecules through tissue, since areas of restricted diffusion may indicate malignancy.
The results showed that 25 of the 50 participants had a breast carcinoma. DWIBS achieved a comparable accuracy to that of the full diagnostic and the abbreviated contrast-enhanced MRI protocols, yielding an excellent negative predictive value of 92%. Only pure microcalcification related ductal carcinoma in-situ (DCIS) without solid tumor—a very early stage of breast cancer—was not detected by any of the MRI techniques. The study was published early online on September 11, 2015, in Radiology.
“If the preliminary findings are confirmed, this approach could have a high potential to be used as an adjunct in the clarification process of unclear lesions on X-ray mammography in breast cancer screening,” said lead author Sebastian Bickelhaupt, MD, a radiologist at DKFZ. “This might help to reduce the number of invasive biopsies and the related anxiety in women who have suspicious findings at mammography.”
DWIBS MRI holds several advantages; the images can be obtained in less than seven minutes, compared with more than 30 minutes for a full breast MRI protocol; and the mean reading time using the unenhanced DWIBS method is less than 30 seconds thanks to MIPS, a technique that allows lesion assessment by reading one summation image instead of multiple single-slice images. The technique however, is in its early stages, and as such is not intended as a standalone screening modality but as an adjunct to X-ray mammography and tomosynthesis.
Related Links:
German Cancer Research Center
University Hospital Heidelberg
Latest MRI News
- Deep Learning Model Predicts Alzheimer’s Disease Outcomes from Baseline MRI
- Blood-Brain Barrier Imaging Adds Risk Insight to Standard Stroke MRI
- AI Body Composition MRI Analysis Predicts Cardiometabolic Disease Risk
- AI MRI Tool Quantifies Muscle Fat to Assess Cardiometabolic Risk
- Advanced MRI Visualizes CSF Motion Changes After Mild Traumatic Brain Injury
- MRI Tool Enables Long-Term Tracking of Transplanted Cardiac Cells
- MRI-Based AI Tool Supports Differentiation of Parkinsonian Syndromes
- MRI-Derived Biomarker Improves Risk Stratification in Glioblastoma
- Combined Imaging Approach Identifies Cause of Heart Attack without Coronary Blockage
- Advanced MRI System Detects Impaired Cardiac Oxygen Use in Minutes
- AI-Enhanced MRI Improves Image Quality in Arrhythmia Patients
- Ultra-Detailed Brain Atlas Enhances Early Detection of Neurological Disorders
- Study Finds Advanced Imaging Significantly Reduces Unnecessary Prostate Biopsies
- New Material Boosts MRI Image Quality
- AI Model Reads and Diagnoses Brain MRI in Seconds
- MRI Scan Breakthrough to Help Avoid Risky Invasive Tests for Heart Patients
Channels
Radiography
view channel
Simple Chest X-Ray Measure Predicts Survival After Lung Cancer Surgery
Obstructive ventilatory disorder, marked by airflow limitation that reduces breathing efficiency, increases postoperative risk in patients with lung cancer. Although surgery offers the best chance of cure,... Read more
AI Detection Tool Improves Identification of Lobular Breast Cancer
Breast cancer screening seeks early detection, yet some subtypes remain difficult to visualize on mammography, risking delayed diagnosis. On average, 1 in 20 women worldwide will develop breast cancer,... Read moreUltrasound
view channelAI Robotic Ultrasound System Automates Echocardiography and Improves Consistency
Echocardiography, an ultrasound examination of the heart, is central to diagnosing and managing cardiovascular disease. Many services struggle with limited availability of skilled sonographers, variable... Read more
Whole Cross-Section Ultrasound System Enables Operator-Independent Imaging
Conventional ultrasound is central to bedside imaging but is limited by a narrow field of view and operator variability. Comprehensive cross-sectional assessment typically requires computed tomography... Read moreNuclear Medicine
view channelMR-Guided Cardiac Mapping System Enables Radiation-Free Procedures
Cardiac electrophysiology procedures are typically guided by X-ray fluoroscopy, which limits soft-tissue visualization and exposes patients and clinical staff to ionizing radiation. Real-time mapping that... Read more
PET Tracer Enables Noninvasive Measurement of Beta Cell Mass
Type 1 diabetes is an autoimmune disease in which the immune system destroys insulin-producing pancreatic beta cells. Loss of these cells destabilizes glucose control and drives complications.... Read more
New Imaging Tool Sheds Light on Tumor Fat Metabolism
Rapidly growing tumors reprogram metabolism to meet high energy demands. While many cancers preferentially consume glucose, lipid utilization by malignant cells is difficult to measure in living subjects.... Read more
Radiopharmaceutical Molecule Marker to Improve Choice of Bladder Cancer Therapies
Targeted cancer therapies only work when tumor cells express the specific molecular structures they are designed to attack. In urothelial carcinoma, a common form of bladder cancer, the cell surface protein... Read moreGeneral/Advanced Imaging
view channel
AI Tool Automates Radiotherapy Planning for Cervical and Prostate Cancer
Cervical cancer causes most of its global mortality in low- and middle-income countries, where radiotherapy capacity and specialist staff are limited. Treatment planning is labor-intensive and can delay... Read more
New Proton Therapy Platform Integrates into Existing Radiotherapy Departments
Mevion Medical Systems (Littleton, MA, USA) has introduced the MEVION S250-FIT Proton Therapy System to the European radiation oncology community at ESTRO 2026, the first proton therapy platform designed... Read more
3D-Printed Intraoral Device Enhances Head and Neck Radiotherapy Accuracy
Ensuring consistent immobilization and soft-tissue positioning is central to safe, effective head and neck radiotherapy, where protection of organs at risk must be balanced with dose accuracy.... Read more
Molecular Imaging Agent Shows Promise for Endometriosis Detection and Monitoring
Diagnosing endometriosis remains challenging, particularly for superficial peritoneal endometriosis, the most common subtype, which is often missed on conventional imaging and typically requires laparoscopic... Read moreImaging IT
view channel
Interactive AI Tool Supports Explainable Lung Nodule Assessment
Lung cancer is a leading cause of cancer mortality, and timely characterization of pulmonary nodules on chest computed tomography (CT) is essential for directing care. Interpreting nodule morphology demands... Read more
Breast Imaging Software Enhances Visualization and Tissue Characterization in Challenging Cases
Breast imaging can be particularly challenging in cases involving small breasts or implants, where image reconstruction and tissue characterization may be limited. Clinicians also need reproducible analysis... Read more
New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read moreIndustry News
view channel
GE HealthCare Highlights AI-Supported Radiation Therapy Tools at ESTRO 2026
At the European Society for Radiotherapy and Oncology (ESTRO) 2026 Congress in Stockholm, GE HealthCare is highlighting Intelligent Radiation Therapy (iRT), MIM Software innovations, and BK Medical surgical... Read more







